Tolazamide: Uses, Dosage, Side Effects & More

Introduction

Tolazamide is an oral blood glucose-lowering medication belonging to the sulfonylurea class, used in the treatment of type 2 diabetes mellitus. Its chemical formula is C14H21N3O3S, and it works by stimulating the release of insulin from pancreatic beta cells to help control high blood sugar levels.

Medical Uses

Tolazamide is primarily indicated for the management of type 2 diabetes mellitus in patients who have not achieved adequate glycemic control through diet and exercise alone. It is often used as a second-line therapy after metformin or in combination with other antidiabetic medications.

Mechanism of Action

Pharmacodynamics

Tolazamide works by binding to sulfonylurea receptors on pancreatic beta cells, leading to the closure of ATP-sensitive potassium channels. This results in the depolarization of the beta cell membrane and the opening of voltage-gated calcium channels, triggering the release of insulin. The increased insulin secretion helps lower blood glucose levels.

Pharmacokinetics

Tolazamide is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 2-4 hours of oral administration. It is extensively bound to plasma proteins (>99%) and undergoes hepatic metabolism. The elimination half-life of tolazamide is approximately 7 hours, and it is excreted primarily in the urine as inactive metabolites.

Interactions

Tolazamide may interact with various medications, including beta-blockers, salicylates, and monoamine oxidase inhibitors. These interactions can potentiate the hypoglycemic effect of tolazamide or reduce its efficacy. Alcohol consumption should be avoided, as it can increase the risk of hypoglycemia.

Administration and Dosage

Dosage Guidelines

The initial dosage of tolazamide for adults is usually 100-250 mg once daily, taken with breakfast or the first main meal. The dosage can be gradually increased based on the patient’s response, up to a maximum of 1000 mg per day in divided doses. Dosage adjustments may be necessary for elderly patients or those with renal impairment.

Forms of Administration

Tolazamide is available as oral tablets in various strengths, including 100 mg, 250 mg, and 500 mg.

Side Effects and Adverse Reactions

Common Side Effects

Common side effects of tolazamide include gastrointestinal disturbances, such as nausea, vomiting, and diarrhea. Hypoglycemia is the most significant adverse effect, and patients should be educated on recognizing and managing its symptoms, such as shakiness, sweating, and confusion.

Severe Adverse Reactions

Rare but severe adverse reactions associated with tolazamide include allergic reactions, hepatic dysfunction, and hematological disorders, such as anemia and leukopenia.

Contraindications and Precautions

Conditions and Situations to Avoid

Tolazamide is contraindicated in patients with known hypersensitivity to sulfonylureas or any of its components. It should be used with caution in patients with renal or hepatic impairment, as well as in pregnant and nursing women.

Precautionary Measures

Patients taking tolazamide should regularly monitor their blood glucose levels and be aware of the signs and symptoms of hypoglycemia. They should also inform their healthcare provider about any other medications they are taking to avoid potential drug interactions.

Clinical Considerations

Efficacy and Benefits

Clinical trials have demonstrated the efficacy of tolazamide in improving glycemic control and reducing the risk of long-term complications associated with diabetes, such as cardiovascular disease and end-organ damage. However, its comparative efficacy with newer antidiabetic agents may be lower.

Risks and Limitations

Long-term use of tolazamide may be associated with an increased risk of cardiovascular events and weight gain. Additionally, its efficacy may decline over time, necessitating the need for additional or alternative therapies.

Patient Management

Patient Education

Patients should be educated on the importance of adhering to their prescribed treatment regimen, as well as the role of diet, exercise, and stress management in controlling their diabetes. They should also be trained to recognize and manage episodes of hypoglycemia.

Lifestyle Modifications

In addition to medication, patients with type 2 diabetes should be encouraged to adopt a healthy lifestyle, including a balanced diet, regular physical activity, and maintaining a healthy body weight. These lifestyle modifications can significantly improve glycemic control and reduce the risk of complications.

Regulatory and Brand Information

Brand Names and Availability

Tolazamide is available under the brand name Tolinase and as a generic drug. It is widely accessible in most countries, and its generic availability makes it a cost-effective option for patients with type 2 diabetes.

Regulatory Status

Tolazamide was approved by the U.S. Food and Drug Administration (FDA) in 1984 for the treatment of type 2 diabetes mellitus. It has since been approved by various regulatory agencies worldwide.

Miscellaneous

Chemical and Physical Properties

Tolazamide is a white to creamy-white powder with a molecular weight of 311.4 g/mol. It is practically insoluble in water and slightly soluble in alcohol. Tolazamide should be stored at room temperature, protected from light and moisture.

Research and Development

While tolazamide remains an important tool in the management of type 2 diabetes, ongoing research is focused on developing newer, more effective antidiabetic agents with improved safety profiles and more convenient dosing schedules.

References and Further Reading

1. Tolazamide” target=”_blank”>PubChem. (2021). Tolazamide. National Center for Biotechnology Information.
2. Drugs and Lactation Database (LactMed) [ Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Tolazamide. [Updated 2021 Feb 15].
3. Patel, D. K., & Sharma, R. T. (2019). Sulfonylureas. In: StatPearls [ Internet]. Treasure Island (FL): StatPearls Publishing.